Guide to Allergy Testing and Immunotherapy: Billing, Coding, and Compliance

By Elizaveta Bannova, Billing Department, WCH

Allergic diseases represent one of the most prevalent chronic health burdens. In the United States, tens of millions of individuals are affected by allergic rhinitis, asthma, food allergies, drug allergies, and contact dermatitis. For clinicians, accurate identification of allergen triggers enables targeted treatment rather than empirical symptom control. For practices, however, allergy services sit at the intersection of clinical precision and high audit exposure, making correct coding, documentation, and payer-policy alignment essential.

Allergy billing is unit-driven, policy-sensitive, and documentation-intensive. Errors most commonly arise from overuse of testing, improper unit reporting, E&M misuse, and inadequate medical necessity documentation.

I. Core CPT Codes for Allergy Testing

Allergy diagnostics fall into two primary categories:

Category	Modality	CPT Range
In vivo testing	Skin-based testing	95004, 95024, 95027, 95044
In vitro testing	Blood (IgE) testing	86003

1. Percutaneous (Prick/Puncture) Testing — CPT 95004

This is the most commonly performed allergy test and the preferred first-line modality for many inhalant and food allergens.

Key Billing Principles

• Unit-based code: 1 unit = 1 allergen tested
• Multiple allergens tested during the same session are reported as multiple units
• Often subject to payer unit caps per date of service (DOS) or benefit year

Documentation Requirements

• Allergen identity and manufacturer
• Concentration and lot number (best practice)
• Test site (back vs. arm)
• Objective measurement (wheal/flare in mm or standardized grading scale)
• Clinical rationale for the number of allergens tested

2. Intradermal Testing — CPT 95024 and 95027

Used primarily when percutaneous testing is negative but clinical suspicion remains high (commonly with aeroallergens, venom, or drug testing). Not typically used for routine food allergy evaluation.

Code	Description	Reporting Concept
95024	Intradermal test, single antigen	Sequential testing per allergen
95027	Intradermal, multiple tests	A series of dilutional or stepwise tests

Compliance Note:
Improper simultaneous use of 95024 and 95027 without clear differentiation of allergens or dilutions is a common audit trigger.

3. Patch Testing — CPT 95044

Used to identify delayed hypersensitivity reactions (e.g., contact dermatitis).

Code Includes

• Application of patches
• Initial reading
• All subsequent readings

Do not bill separately for follow-up visits solely for patch test interpretation.

4. In Vitro IgE Testing — CPT 86003

Serologic allergen-specific IgE testing.

Appropriate Use Cases

• Severe dermatitis preventing skin testing
• Patient cannot discontinue antihistamines
• High anaphylaxis risk

Billing Rule
If the specimen is sent to an outside laboratory, the ordering provider may bill only for specimen collection — not 86003.

II. Immunotherapy Coding

Immunotherapy billing is split into:

Component	Purpose	CPT Codes
Provision of extract	Preparation/mixing of antigen serum	95165, 95144
Administration	Injection of prepared serum	95115, 95117

1. Allergen Extract Preparation

Code	Description	Use Case
95165	Multi-dose vial preparation	Most common code
95144	Single-dose vial	Prepared for use by another physician

Critical Concept:
Units represent doses, not allergens. Billing based on the number of allergens rather than doses is a frequent compliance error.

2. Administration Codes

Code	Description
95115	Single injection
95117	Two or more injections

These are mutually exclusive per DOS and typically billed once per visit.

III. E&M Services and Modifier 25

E&M may be billed on the same day as allergy testing or injections only when the visit includes a separately identifiable medical service.

Appropriate Example
Patient presents for scheduled immunotherapy injection but is also evaluated for new-onset uncontrolled hypertension requiring medical decision-making.

Audit Risk

• Routine addition of E&M to injection visits
• “Cloned” documentation
• Lack of a separate assessment

IV. Documentation Standards

Allergy services are highly scrutinized. Documentation must establish:

Medical Necessity

• Symptom severity
• Impact on daily function
• Failure of conservative therapy

Testing Details

• Allergen list
• Method used
• Measurement of response
• Time interval between placement and reading

Immunotherapy Records

• Mixing logs
• Extract composition
• Dose escalation schedule
• Reaction monitoring

V. Supervision Requirements

Allergy testing and immunotherapy typically require direct supervision — the physician must be present in the office suite and immediately available.

VI. Payer Limitations and Frequency Edits

Payers frequently impose:

• Unit caps per DOS
• Annual test maximums
• Frequency limits (e.g., repeat testing only after defined intervals)

Failure to verify these leads to denials and recoupments.

VII. Audit Risk Mitigation Strategies

Risk Area	Preventive Action
Over-testing	Link each allergen to clinical relevance
Duplicate testing	Verify prior testing history
Improper units	Audit dose calculations
E&M misuse	Require documentation review before claim release

Missing signatures

Enforce timely provider sign-off

VIII. Operational Metrics

High-performing practices monitor:

• Clean Claim Rate ≥ 98%
• First-Pass Resolution ≥ 95%
• Denial rate for allergy services < 5%

Conclusion

Allergy services combine clinical complexity with strict reimbursement oversight. Practices that succeed financially maintain alignment between medical necessity, unit integrity, and documentation precision. Structured internal controls and proactive payer policy review are essential to reduce audit exposure while delivering effective patient care.